Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery

Ovid Technologies (Wolters Kluwer Health) - Tập 116 Số 22 - Trang 2544-2552 - 2007
Gavin J. Murphy1, Barnaby C Reeves2, Chris Rogers2, Syed I.A. Rizvi2, Lucy Culliford2, Gianni D. Angelini2
1Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, UK
2From the Bristol Heart Institute, University of Bristol, Bristol, United Kingdom.

Tóm tắt

Background— Red blood cell transfusion can both benefit and harm. To inform decisions about transfusion, we aimed to quantify associations of transfusion with clinical outcomes and cost in patients having cardiac surgery. Methods and Results— Clinical, hematology, and blood transfusion databases were linked with the UK population register. Additional hematocrit information was obtained from intensive care unit charts. Composite infection (respiratory or wound infection or septicemia) and ischemic outcomes (myocardial infarction, stroke, renal impairment, or failure) were prespecified as coprimary end points. Secondary outcomes were resource use, cost, and survival. Associations were estimated by regression modeling with adjustment for potential confounding. All adult patients having cardiac surgery between April 1, 1996, and December 31, 2003, with key exposure and outcome data were included (98%). Adjusted odds ratios for composite infection (737 of 8516) and ischemic outcomes (832 of 8518) for transfused versus nontransfused patients were 3.38 (95% confidence interval [CI], 2.60 to 4.40) and 3.35 (95% CI, 2.68 to 4.35), respectively. Transfusion was associated with increased relative cost of admission (any transfusion, 1.42 times [95% CI, 1.37 to 1.46], varying from 1.11 for 1 U to 3.35 for >9 U). At any time after their operations, transfused patients were less likely to have been discharged from hospital (hazard ratio [HR], 0.63; 95% CI, 0.60 to 0.67) and were more likely to have died (0 to 30 days: HR, 6.69; 95% CI, 3.66 to 15.1; 31 days to 1 year: HR, 2.59; 95% CI, 1.68 to 4.17; >1 year: HR, 1.32; 95% CI, 1.08 to 1.64). Conclusions— Red blood cell transfusion in patients having cardiac surgery is strongly associated with both infection and ischemic postoperative morbidity, hospital stay, increased early and late mortality, and hospital costs.

Từ khóa


Tài liệu tham khảo

10.1097/01.CCM.0000217920.48559.D8

10.1016/S0003-4975(01)03308-2

10.1136/bmj.325.7368.803

10.1097/00000542-199802000-00009

10.1097/01.CCM.0000104112.34142.79

10.1001/jama.288.12.1499

10.1046/j.1537-2995.1999.39101070.x

Moise SF, Higgins MJ, Colquhoun AD. A survey of blood transfusion practice in UK cardiac surgery units. Crit Care. 2001; 5 (suppl A): 4. Abstract.

10.1001/jama.291.20.2457

10.1016/S0022-5223(98)70422-2

10.1016/S0003-4975(01)02778-3

10.1016/S0022-5223(02)73291-1

10.1097/01.CCM.0000195012.54682.F3

10.1016/j.athoracsur.2004.04.083

10.1016/0003-4975(95)00808-X

UK Department of Health. NHS reference costs. Available at: http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en. Accessed January 2007.

10.1093/ije/dyh276

10.1016/j.athoracsur.2006.06.020

10.1001/jama.1993.03500230106037

10.1111/j.0041-1132.2004.04128.x

10.1097/01.CCM.0000150655.75519.02

10.1046/j.1537-2995.1999.39399219284.x

10.1046/j.1365-3148.2000.00267.x

10.1182/blood-2005-07-2668

10.1016/j.tmrv.2005.08.001

10.1172/JCI1841

10.1378/chest.116.5.1233

10.1161/circ.105.9.1135

10.1056/NEJMra043430

10.1046/j.1537-2995.2002.00181.x

10.1136/bmj.38103.735266.55

10.1152/ajpheart.00884.2004

10.1097/00000542-200010000-00023

10.1097/00000542-200605000-00005

10.1056/NEJM199902113400601

10.1097/01.shk.0000156668.81757.0c

Utoh J, Goto H, Obayashi H, Hirati T, Miyauchi Y. Oxygen metabolism after cardiopulmonary bypass. J Cardiovasc Surg. 1996; 37: 119–120.

Thông tin
Thông tin xuất bản

Ovid Technologies (Wolters Kluwer Health)

Tập 116 Số 22

2544-2552

Thông tin tác giả